Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Coenzyme q10 + vitamin e is a combination dietary supplement containing two antioxidant compounds, coenzyme Q10 (ubiquinone) and vitamin E (tocopherol). Both are lipid-soluble antioxidants that help protect cells from oxidative damage. Coenzyme Q10 is involved in mitochondrial energy production and cellular respiration, while vitamin E protects cell membranes from lipid peroxidation. The combination has been studied for enhanced antioxidant and anti-inflammatory effects compared to either agent alone, with evidence suggesting synergistic benefits in reducing inflammation markers such as C-reactive protein and providing greater protection against oxidative stress[1][5][6]. It has also shown potential anxiolytic and antidepressant effects under stress conditions in animal models by modulating inflammatory pathways[6]. This combination is primarily marketed as a dietary supplement for general health, cardiovascular support, neuroprotection, and adjunctive therapy in various conditions associated with increased oxidative stress.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on coenzyme q10 + vitamin e.